Rifametane

TargetMol
Product Code: TAR-T26083
Supplier: TargetMol
CodeSizePrice
TAR-T26083-100mg100mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26083-500mg500mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C

Images

1 / 1

Further Information

Bioactivity:
Rifametane is a new semi-synthetic rifamycin, an antibiotic produced naturally by the bacterium Amycolatopsis rifamycinica.
CAS:
94168-98-6
Molecular Weight:
836.98
Purity:
0.98
SMILES:
CCN(CC)C(C)=NN=Cc1c(O)c2c3C(=O)[C@]4(C)Oc3c(C)c(O)c2c(O)c1NC(=O)\C(C)=C/C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C/O4 |w:9.9,7.7,c:36,38,60|

References

Kelkar MS, Saraf AP, Bakhle DS, Nazare V, Ajay S, Hegde S, Lal HM, Cooverji ND, Bruzzese T. Pharmacokinetic profile of a new 3-azinomethyl rifamycin (SPA-S-565) in volunteers as compared with conventional rifampicin. Int J Clin Pharmacol Res. 1998;18(3):137-43. PubMed PMID: 9825270. Bruzzese T, Rimaroli C, Bonabello A, Mozzi G, Ajay S, Cooverj ND. Pharmacokinetics and tissue distribution of rifametane, a new 3-azinomethyl-rifamycin derivative, in several animal species. Arzneimittelforschung. 2000 Jan;50(1):60-71. PubMed PMID: 10683718. Potkar C, Gogtay N, Gokhale P, Kshirsagar NA, Ajay S, Cooverji ND, Bruzzese T. Phase I pharmacokinetic study of a new 3-azinomethyl-rifamycin (rifametane) as compared to rifampicin. Chemotherapy. 1999 May-Jun;45(3):147-53. PubMed PMID: 10224335.